|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Net revenues | |||||
| Product | |||||
| Service | |||||
| Operating (expenses) income | |||||
| Merchandise costs | |||||
| Fulfillment expenses | |||||
| Selling and marketing expenses | |||||
| General and administrative expenses | |||||
| Research and development expenses | |||||
| Technology and content expenses | |||||
| Goodwill impairment loss | |||||
| Other operating income, net | |||||
| (Loss) income from operations | |||||
| Interest expense | |||||
| Interest income | |||||
| Other loss, net | |||||
| (Loss) income before income taxes and share of loss in equity method investments | |||||
| Income tax benefits (expenses) | |||||
| Share of loss in equity method investments | |||||
| Net (loss) income | |||||
| Foreign currency translation adjustments | |||||
| Total comprehensive (loss) income | |||||
| Accretion of convertible redeemable preferred shares | |||||
| Total comprehensive loss attributable to ordinary shareholders | |||||
| Net loss attributable to ordinary shareholders of the Company | |||||
| Net (loss) earnings per share | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average number of shares used in calculating net (loss) income per ordinary share | |||||
| Basic | |||||
| Diluted | |||||
Loading...